IGM Biosciences CEO Fred Schwarzer's 2022 pay falls 46% to $5.3M
IGM Biosciences reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
IGM Biosciences reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at IGM Biosciences received on average a compensation package of $3M, a 57% decrease compared to previous year.
Average pay of disclosed executives at IGM Biosciences
Fred Schwarzer, Chief Executive Officer, received $5.3M in total, which decreased by 46% compared to 2021. 81% of Schwarzer's compensation, or $4.3M, was in option awards. Schwarzer also received $356K in non-equity incentive plan, $622K in salary, as well as $6.8K in stock awards.
Bruce Keyt, Chief Scientific Officer, received a compensation package of $1.8M, which decreased by 60% compared to previous year. 50% of the compensation package, or $928K, was in option awards.
Chris H. Takimoto, M.D., Ph.D., F.A.C.P, Chief Medical Officer, earned $1.8M in 2022, a 78% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2023.